User profiles for Camilo Rojas
 | Camilo RojasAssistant Professor, Johns Hopkins University Verified email at jhmi.edu Cited by 8189 |
[PDF][PDF] El Chocó biogeográfico: ambiente físico
IC Poveda, CA Rojas, A Rudas… - … diversidad biótica IV, El …, 2004 - researchgate.net
Con base en el análisis en conjunto de varios factores físico-ambientales (clima, geología,
suelos, relieve) y apoyados en las facilidades de síntesis de los Sistemas de Información …
suelos, relieve) y apoyados en las facilidades de síntesis de los Sistemas de Información …
Condiciones de vida y jerarquías sociales en el norte de Suramérica: el caso de la población muisca en Tibanica, Soacha
…, L Aristizabal, MA Corcione, C Rojas… - … América Latina y …, 2011 - journals.iai.spk-berlin.de
Este artículo presenta un primer informe de la investigación de un cementerio muisca Tardío
de la Sabana de Bogotá, Colombia. Los resultados que se presentan sugieren que la …
de la Sabana de Bogotá, Colombia. Los resultados que se presentan sugieren que la …
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1
…, AG Thomas, DV Ferraris, T Tsukamoto, CJ Rojas… - Cancer research, 2010 - AACR
Mutation at the R132 residue of isocitrate dehydrogenase 1 (IDH1), frequently found in
gliomas and acute myelogenous leukemia, creates a neoenzyme that produces 2-…
gliomas and acute myelogenous leukemia, creates a neoenzyme that produces 2-…
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide (BPTES)
…, SJ Mcbryant, T Tsukamoto, C Rojas… - Biochemical …, 2007 - portlandpress.com
The release of GA (mitochondrial glutaminase) from neurons following acute ischaemia or
during chronic neurodegenerative diseases may contribute to the propagation of glutamate …
during chronic neurodegenerative diseases may contribute to the propagation of glutamate …
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …
…, R Rodriguez, MA Carducci, C Rojas… - Journal of Nuclear …, 2012 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen-independent, …
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen-independent, …
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor
C Rojas, M Stathis, AG Thomas… - Anesthesia & …, 2008 - journals.lww.com
BACKGROUND: Palonosetron is a 5-HT 3-receptor antagonist (5-HT 3-RA) that has been
shown to be superior to other 5-HT 3-RAs in phase III clinical trials for the prevention of acute, …
shown to be superior to other 5-HT 3-RAs in phase III clinical trials for the prevention of acute, …
Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors
Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a potent and selective
allosteric inhibitor of kidney-type glutaminase (GLS) that has served as a molecular probe …
allosteric inhibitor of kidney-type glutaminase (GLS) that has served as a molecular probe …
Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
C Rojas, AG Thomas, J Alt, M Stathis, J Zhang… - European journal of …, 2010 - Elsevier
Palonosetron is a 5-HT 3 receptor antagonist that has demonstrated superiority in preventing
both acute and delayed emesis when compared to older first generation 5-HT 3 receptor …
both acute and delayed emesis when compared to older first generation 5-HT 3 receptor …
[HTML][HTML] Miasis cutánea por Cochliomyia hominivorax asociada a dermatitis seborreica: Case report
P Calderón, C Rojas, W Apt, D Castillo - Revista médica de Chile, 2017 - SciELO Chile
vol. 145 número2 Consecuencias de la fluoración del agua potable en la salud humana
Leiomiomatosis benigna metastásica: reporte de caso clínico índice de autores índice de …
Leiomiomatosis benigna metastásica: reporte de caso clínico índice de autores índice de …
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Targeting glutamine metabolism via pharmacological inhibition of glutaminase has been
translated into clinical trials as a novel cancer therapy, but available drugs lack optimal safety …
translated into clinical trials as a novel cancer therapy, but available drugs lack optimal safety …